What GT Biopharma Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Breen Michael Martin | Executive Chairman/Interim CEO | Aug 11 | Grant / award · A | +200,000 | $0.29 | +$57.4K | 856,218 |
| Ohri Manu | CFO & Secretary | Aug 11 | Other Transaction · J | +200,000 | $0.29 | +$57.4K | 300,000 |
| Ohri Manu | CFO & Secretary | Aug 11 | Other Transaction · J | −200,000 | $0.29 | −$57.4K | 0 |
| Ohri Manu | CFO & Secretary | Aug 11 | Grant / award · A | +200,000 | $0.29 | +$57.4K | 200,000 |
| Breen Michael Martin | Executive Chairman/Interim CEO | Apr 11 | Open-market buy · P | +50,000 | $0.50 | +$25K | 656,218 |
| Ohri Manu | CFO & Secretary | Apr 06 | Open-market buy · P | +50,000 | $0.50 | +$25K | 50,000 |
| Breen Michael Martin | Exec. Chair. and Interim CEO | Jul 15 | Grant / award · A | +278,058 | — | — | 606,218 |
| Ohri Manu | CFO & Secretary | Jul 15 | Other Transaction · J | +100,000 | — | — | 100,000 |
| Ohri Manu | CFO & Secretary | Jul 15 | Other Transaction · J | −100,000 | — | — | 0 |
| Ohri Manu | CFO & Secretary | Jul 15 | Grant / award · A | +100,000 | — | — | 100,000 |
| Breen Michael Martin | Director | Feb 25 | Derivative Conversion · C | +9,859 | $3.40 | +$33.5K | 328,160 |
| Breen Michael Martin | Director | Feb 25 | Derivative Conversion · C | +40,243 | $3.40 | +$137K | 318,301 |
| Wendel Bruce | Director | Feb 16 | Grant / award · A | +347,572 | — | — | 352,655 |
| Berk Gregory | Director | Feb 16 | Grant / award · A | +278,058 | — | — | 278,058 |
| Breen Michael Martin | Director | Feb 16 | Grant / award · A | +278,058 | — | — | 278,058 |
| Wendel Bruce | Director | Dec 22 | Open-market buy · P | +441 | $8.73 | +$3.85K | 5,083 |
| Wendel Bruce | Director | Dec 22 | Open-market buy · P | +1,374 | $8.87 | +$12.2K | 4,642 |
| Weldon Steven W | Insider | Dec 22 | Open-market sale · S | −47,978 | $0.40 | −$19.2K | 3,720,000 |
| Weldon Steven W | Insider | Dec 21 | Open-market sale · S | −35,722 | $0.34 | −$12.1K | 3,767,978 |
| Weldon Steven W | Insider | Dec 21 | Open-market sale · S | −50,000 | $0.33 | −$16.5K | 3,803,700 |
Loading...
